China Pharma Holdings (CPHI) Inventory Average (2011 - 2026)

China Pharma Holdings' Inventory Average history runs 16 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Inventory Average fell 38.01% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 38.01% YoY) and the FY2025 annual result came in at $1.9 million, down 36.56% from the prior year.
• Inventory Average was $1.6 million for Q1 2026 at China Pharma Holdings, down from $1.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $3.8 million in Q3 2023 and bottomed at $1.6 million in Q1 2026.
• A 5-year average of $3.0 million and a median of $3.2 million in 2022 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average soared 30.75% — and 2026, when it plunged 38.01%.
• China Pharma Holdings' Inventory Average stood at $2.9 million in 2022, then soared by 30.75% to $3.8 million in 2023, then slumped by 37.54% to $2.4 million in 2024, then tumbled by 31.35% to $1.6 million in 2025, then retreated by 4.62% to $1.6 million in 2026.
• Business Quant data shows CPHI's Inventory Average at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $2.2 million in Q3 2025.